The first phase of the Mere Grange development in St Helens was completed in July 2018 and comprised 90,500 sq ft split across four individual buildings, ranging in size from 18,500 sq ft to 26,350 sq ft. Each unit is self-contained, built to a high specification and designed to appeal to the needs of a wide range of logistics and industrial users.
Phase 2 comprises a 51,400 sq ft unit which is currently under construction and has been pre-let to a specialist commercial laundry firm, Synergy LMS, on a 25-year lease. Caddick Construction are the contractors responsible for the build and completion is anticipated next month.
-- Advertisement --
Network Space has also recently secured planning for a 20,000 sq ft unit on the final phase which has been pre-let to an electrical distribution business. Construction of the unit is due to commence on site next month with completion before the end of the year.
Stephen Barnes, Managing Director (Development) at Network Space, said: "We are delighted with progress at Mere Grange as we near completion of Phase 2 and shortly look to commence Phase 3.
"In attracting the calibre of occupiers we have, Mere Grange has beaten off strong competition from other sites in the region. This is not only testament to the quality of accommodation we are delivering at the site but also the quality of the location and our proactive approach in responding to occupiers needs.
"I'd like to thank the professional team for their hard work, together with our partners St Helens MBC and Homes England who have been actively involved in supporting the project. We look forward to successfully completing the final phase later this year."
Mere Grange is being developed in association with Homes England, St Helens Council and Liverpool City Region Combined Regional Authority.
Cllr Derek Long, Leader of St Helens Council, added: "The development at Mere Grange is precisely the type of new employment space we require in St Helens in that it can support multiple different sectors. The Borough has a tradition in pharmaceuticals, and health and medical technology businesses."
(CM/JG)
